Literature DB >> 3931595

Physiologic assessment of surgical diagnosis-related groups.

L R Del Guercio, J A Savino, J C Morgan.   

Abstract

Although (diagnostic related groups) DRGs were originally devised as a research instrument for the evaluation of medical resource allocation, no studies have been reported that compare the actual physiologic status of patients with DRG classification. At the Westchester Medical Center, a University tertiary referral center, 100 consecutive high-risk elective surgical patients entered a preoperative intensive care unit for a prospective analysis of physiologic assessment, resource utilization, DRG classification, and outcome. Swan-Ganz catheters inserted 1 or 2 days before surgery were used to compute physiologic profiles and stage according to previously published criteria. Risk was determined by age, associated conditions, and magnitude of the proposed operation. There were no patients in stage 1; 55% in stage 2; 41% in stage 3; and 4% in stage 4, which accounted for three of the four total deaths. The 41% of patients over age 70 all had DRG comorbidity factors, but none died. All in stages 3 and 4 had comorbidity factors, as did 87% in stage 2. In 53% of the patients, the physiologic profile provided data necessary for preoperative "fine tuning"; in 37%, for volume expansion; in 23%, for inotropic therapy; and in 17%, for pulmonary therapy. Reoperation was required in 17% and contributed to the long average length of stay (LOS) of 24.5 days. In spite of case severity and comorbidity factors, LOS in the postoperative ICU was only 3 days. There were no significant differences in patients with cancer DRGs. Significant differences between stages 2 and 3 were found for pulmonary wedge pressure, right ventricular stroke work, pulmonary vascular resistance, and pulmonary shunt fraction. The 4% who died all had advanced liver disease. Although the DRG system as set up by the Health Care Financing Administration (HCFA) correctly predicts that age and comorbidity factors lead to increased utilization of resources, the extent to which they underestimate the increased needs of these patients will lead to financial disaster. Compensation for comorbidity factors and advanced age are not cumulative, but patients over 70 had an average of 2.5 comorbidity factors and required an average 26.5 days hospitalization. DRGs allowed only 15% extra reimbursement for these complex cases. High-risk, referred surgical patients are much sicker than they appear to the DRG system, and in all 100 cases compensation was grossly inadequate.

Entities:  

Mesh:

Year:  1985        PMID: 3931595      PMCID: PMC1250956          DOI: 10.1097/00000658-198510000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  11 in total

1.  The automated physiologic profile.

Authors:  J D Cohn; P E Engler; L R Del Guercio
Journal:  Crit Care Med       Date:  1975 Mar-Apr       Impact factor: 7.598

2.  Circulatory response to trauma of surgical operations.

Authors:  G H CLOWES; L R DEL GUERCIO
Journal:  Metabolism       Date:  1960-01       Impact factor: 8.694

3.  Multifactorial index of cardiac risk in noncardiac surgical procedures.

Authors:  L Goldman; D L Caldera; S R Nussbaum; F S Southwick; D Krogstad; B Murray; D S Burke; T A O'Malley; A H Goroll; C H Caplan; J Nolan; B Carabello; E E Slater
Journal:  N Engl J Med       Date:  1977-10-20       Impact factor: 91.245

4.  Surgical streams in the flow of health care financing. The role of surgery in national expenditures: what costs are controllable?

Authors:  F D Moore
Journal:  Ann Surg       Date:  1985-02       Impact factor: 12.969

5.  The impact of prospective payment on clinical research.

Authors:  C K Davis
Journal:  JAMA       Date:  1985-02-01       Impact factor: 56.272

6.  Institutional responses to prospective payment based on diagnosis-related groups. Implications for cost, quality, and access.

Authors:  R S Stern; A M Epstein
Journal:  N Engl J Med       Date:  1985-03-07       Impact factor: 91.245

7.  Monitoring operative risk in the elderly.

Authors:  L R Del Guercio; J D Cohn
Journal:  JAMA       Date:  1980-04-04       Impact factor: 56.272

8.  Effects of anesthetics on the heart.

Authors:  H L Price; S T Ohnishi
Journal:  Fed Proc       Date:  1980-04

9.  Aortic aneurysm repair. Reduced operative mortality associated with maintenance of optimal cardiac performance.

Authors:  A D Whittemore; A W Clowes; H B Hechtman; J A Mannick
Journal:  Ann Surg       Date:  1980-09       Impact factor: 12.969

10.  Hemodynamic and oxygen transport patterns in surviving and nonsurviving postoperative patients.

Authors:  R D Bland; W C Shoemaker; E Abraham; J C Cobo
Journal:  Crit Care Med       Date:  1985-02       Impact factor: 7.598

View more
  6 in total

1.  Reducing the costs of ICU admission in Canada without diagnosis-related or case-mix groupings.

Authors:  M J Girotti; S J Brown
Journal:  Can Anaesth Soc J       Date:  1986-11

2.  Potential economic impact of applying DRG-based prospective payment categories to inflammatory bowel disease patients.

Authors:  S P Vulgaropulos; C B Lyle; J T Sessions
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

3.  Resolving the cost/access conflict: the case for a national health program.

Authors:  S Woolhandler; D U Himmelstein
Journal:  J Gen Intern Med       Date:  1989 Jan-Feb       Impact factor: 5.128

4.  Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery. A prospective, randomized clinical trial.

Authors:  J F Berlauk; J H Abrams; I J Gilmour; S R O'Connor; D R Knighton; F B Cerra
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

5.  Comparison of postoperative mortality in VA and private hospitals.

Authors:  J F Stremple; D S Bross; C L Davis; G O McDonald
Journal:  Ann Surg       Date:  1993-03       Impact factor: 12.969

Review 6.  Perioperative care of the immunocompromised patient.

Authors:  J Yee; N V Christou
Journal:  World J Surg       Date:  1993 Mar-Apr       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.